Does PEMBROLIZUMAB Cause Pulmonary embolism? 745 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 745 reports of Pulmonary embolism have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.9% of all adverse event reports for PEMBROLIZUMAB.
745
Reports of Pulmonary embolism with PEMBROLIZUMAB
0.9%
of all PEMBROLIZUMAB reports
210
Deaths
486
Hospitalizations
How Dangerous Is Pulmonary embolism From PEMBROLIZUMAB?
Of the 745 reports, 210 (28.2%) resulted in death, 486 (65.2%) required hospitalization, and 94 (12.6%) were considered life-threatening.
Is Pulmonary embolism Listed in the Official Label?
Yes, Pulmonary embolism is listed as a known adverse reaction in the official FDA drug label for PEMBROLIZUMAB.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Pulmonary embolism?
RIVAROXABAN (3,282)
LENALIDOMIDE (2,976)
APIXABAN (2,714)
ETHINYL ESTRADIOL\ETONOGESTREL (2,370)
TESTOSTERONE (2,043)
RITUXIMAB (1,764)
ADALIMUMAB (1,663)
PREDNISONE (1,586)
METHOTREXATE (1,508)
DEXAMETHASONE (1,336)
Which PEMBROLIZUMAB Alternatives Have Lower Pulmonary embolism Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G